[1]
G. M. Abas, F. Sjatha, and Y. . Rosana, “The Risk of Latent Tuberculosis Reactivation in COVID-19 Therapy”, J Biomedika dan Kesehat, vol. 6, no. 3, pp. 363–372, Dec. 2023.